BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250908
DTEND;VALUE=DATE:20250910
DTSTAMP:20260515T044410
CREATED:20250528T153145Z
LAST-MODIFIED:20250528T153258Z
UID:41163-1757289600-1757462399@www.pharmajournalist.com
SUMMARY:Wearable Injectors and Connected Devices USA
DESCRIPTION:Engage in the Latest Innovations in Wearable Injectors and Connected Devices! SAE Media Group’s 3rd Annual Wearable Injectors and Connected Devices USA Conference returns to Boston on September 8–9\, 2025\, bringing together the latest innovations in connected\, on-body drug delivery. Designed for professionals in injectable drug delivery and digital health\, this two-day event will explore critical advancements in large-volume drug delivery\, digital integration\, and user-centric design. Through real-world case studies and expert-led sessions\, you’ll gain actionable insights into the technologies and strategies shaping the future of combination products. Take part in a unique platform to connect and network with key players across pharma and device development\, from R&D and engineering to human factors and regulatory affairs. Whether you’re optimizing your current portfolio or exploring new drug-device opportunities\, this is your chance to stay ahead in a rapidly evolving field and be part of the conversation to shape its future. \nTo know more click here
URL:http://www.pharmajournalist.com/event/wearable-injectors-and-connected-devices-usa-2025/
LOCATION:COURTYARD BY MARRIOTT BOSTON DOWNTOWN\, 275 Tremont St\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="SAE Media Group":MAILTO:marketingteamlondon@saemediagroup.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250909
DTEND;VALUE=DATE:20250912
DTSTAMP:20260515T044410
CREATED:20250620T104212Z
LAST-MODIFIED:20250624T105625Z
UID:41327-1757376000-1757635199@www.pharmajournalist.com
SUMMARY:4th PAT & Real Time Quality Summit
DESCRIPTION:The 4th PAT & Real Time Quality Summit is the leading industry-specific forum for Process Analytical Technology (PAT) professionals in the biotech and pharmaceutical sectors. Taking place at a pivotal time\, with the recent release of USP General Chapter <1037> and anticipated FDA guidelines on PAT due in July 2025\, this summit is tailored to help organizations stay ahead of regulatory shifts and technological advancements. \nBringing together over 80+ PAT experts from leading pharmaceutical companies\, biotechs\, and CDMOs\, the summit will address critical challenges such as high investment costs\, integration with legacy systems\, and data management. Through real-world case studies\, panel discussions\, and strategic roadmaps\, you will explore how PAT is rapidly advancing in areas like biopharmaceuticals\, personalized medicine\, and complex therapies. \nJoin your peers this September to: \n\nBenchmarking strategies with top industry leaders and exploring cutting-edge technologies.\nOvercoming tech transfer challenges for small molecules and complex therapies.\nUnderstanding new FDA guidelines and aligning with GMP compliance.\nDemonstrating ROI and gaining executive buy-in through improved efficiency and reduced batch failures.\nReal-Time Release Testing\, enabling faster timelines while maintaining high quality standards.\n\nYou are guaranteed to leave with actionable insights into PAT integration across the drug development lifecycle—from regulatory updates to real-time release strategies—ensuring smoother approvals\, improved manufacturing processes\, and enhanced product consistency. \nWith speakers from renowned organizations such as AstraZeneca\, GlaxoSmithKline\, and Pfizer\, this summit provides an invaluable platform to exchange ideas\, form collaborations\, and successfully navigate the future of PAT in pharma and biopharma. \nDon’t miss this opportunity to connect with the brightest minds in PAT and help shape the next generation of pharma manufacturing.
URL:http://www.pharmajournalist.com/event/4th-pat-real-time-quality-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250909
DTEND;VALUE=DATE:20250911
DTSTAMP:20260515T044410
CREATED:20250715T155945Z
LAST-MODIFIED:20250715T155945Z
UID:41513-1757376000-1757548799@www.pharmajournalist.com
SUMMARY:2nd ADC & Novel Conjugates Partnering & Investment Summit
DESCRIPTION:Refine your strategy\, sharpen your positioning\, and meet the right partners – all at the most efficient networking event of the ADC conference calendar. \nBack for its second year\, the ADC Partnering & Investment Summit unites 100+ top ADC companies\, pharma leaders\, and investors for hyper-aligned and more efficient business networking.\nUnite with other ADC business development leaders where cutting-edge science meets strategic networking: \n\nConnect directly with decision-makers in a less competitive setting\n\n\nUnderstand how others are positioning themselves to refine your own differentiation\n\n\nGain insights from scientific pioneers shaping the future of ADCs to define your strategic direction\n\nVIEW THE FULL EVENT GUIDE \nSecure your place here or get in touch with the team – info@hansonwade.com
URL:http://www.pharmajournalist.com/event/2nd-adc-novel-conjugates-partnering-investment-summit/
LOCATION:Hyatt Regency Boston\, One Ave. de Lafayette\, Boston\, MA\, 02111\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:General Enquiries: info@hansonwade.com or Partnership Enquiries: sponsor@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250922
DTEND;VALUE=DATE:20250926
DTSTAMP:20260515T044410
CREATED:20250606T105932Z
LAST-MODIFIED:20250606T105932Z
UID:41213-1758499200-1758844799@www.pharmajournalist.com
SUMMARY:15th World Clinical Biomarkers & Companion Diagnostics Summit
DESCRIPTION:Fuelled by industry excitement like the world-first approval of a digital pathology CDx\, the biomarker and diagnostics field continues to surge. \nUniting 600+ precision medicine experts this September\, the 15th World Clinical Biomarkers & Companion Diagnostics Summit returns with a refreshed 4-day\, 3-track\, 50+-speaker program\, ready to facilitate connection-making and knowledge-sharing to bring affordable precision healthcare to patients with unmet need. \n\n600+ attendees from biopharma and diagnostic providers\n50+ precision medicine experts on the speaker faculty\n66+ data-driven presentations spanning the end-to-end of drug-diagnostic co-development\n\nEvent guide: https://ter.li/dr5749 \nRegister (FREE* tickets available for biopharma!): https://ter.li/4zaizd
URL:http://www.pharmajournalist.com/event/15th-world-clinical-biomarkers-companion-diagnostics-summit/
LOCATION:Westin Boston Seaport District\, 425 Summer St\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250923
DTEND;VALUE=DATE:20250926
DTSTAMP:20260515T044410
CREATED:20250528T075314Z
LAST-MODIFIED:20250528T075314Z
UID:41156-1758585600-1758844799@www.pharmajournalist.com
SUMMARY:7th Exosome-Based Therapeutic Development Summit
DESCRIPTION:Showcasing biopharma innovation in 2025\, the 7th Exosome-Based Therapeutics Development Summit returns to Boston as the industry’s only dedicated forum covering the full exosome development pipeline\, from discovery and optimized characterization to scalable manufacturing and clinical translation. \n \nThis year’s Summit brings together key players from Direct Biologics\, Rion\, Aegle Therapeutics\, Aruna Bio\, EXO Biologics\, and more\, as the field accelerates toward the first-ever exosome and EV approvals. \nAcross three content-packed days\, you’ll gain actionable insights and strategic takeaways to support your journey from early-stage research to commercialization. \nJoin 80+ key exosome and extra-cellular vesicle experts specializing in Exosome Biology\, R&D\, CMC to Business Development for an unrivalled learning and networking opportunity to roadmap the therapeutic efficacy and delivery potential of exosomes and EVs towards commercialization and patients in need. \nDon’t miss the chance to lead this field by driving breakthroughs in regenerative and precision medicine and position your pipeline for success in this rapidly advancing space. \nWant to find out more? Download the Official 2025 Brochure here: https://ter.li/c1jk7p \nTo access tickets & discounts\, follow this link: https://ter.li/pi0pdc
URL:http://www.pharmajournalist.com/event/7th-exosome-based-therapeutic-development-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250929
DTEND;VALUE=DATE:20251002
DTSTAMP:20260515T044410
CREATED:20250618T133545Z
LAST-MODIFIED:20250724T113321Z
UID:41299-1759104000-1759363199@www.pharmajournalist.com
SUMMARY:6th Genome Editing Therapeutics Summit
DESCRIPTION:With baby KJ successfully receiving the world’s first personalized CRISPR therapy\, alongside continued innovation across in vivo and base editing\, and rapid ex vivo clinical progress\, the genome editing field stands at a pivotal juncture. \nTo mark this definitive CRISPR milestone\, the 6th Genome Editing Therapeutics Summit returns to Boston to celebrate ongoing progress\, whilst also tackling end-to-end challenges from discovery through to commercial strategy. \nUnite with the industry’s leading minds\, as they advance delivery specificity\, spearhead in vivo editing\, ensure precise targeting\, improve translatability\, and build robust clinical strategies to unlock precise\, durable and safe therapeutics. \nThe 2025 Expert Speaker Line-up Includes: \n\nKiran Musunru\, Professor\, Translational Research\, University of Pennsylvania\nTJ Cradick\, Chief Technology Officer\, HuidaGene Therapeutics\nNageswara Kollu\, Senior Director\, Gene Therapy\, Apellis Pharmaceuticals\nAlexandria Petrusich\, Vice President\, Clinical Science\, Prime Medicine\nBradley Ringeisen\, Executive Director\, Innovative Genomics Institute\nChris Brown\, Vice President\, Discovery\, Metagenomi\nAnjulika Chawla\, Vice President\, Medical Affairs\, Clinical Lead\, Bluebird Bio\n\nAlongside 20+ data-driven presentations\, this year’s program will feature a deep-dive workshop dedicated to the impact of baby KJ\, led by Innovative Genomics Institute\, HuidaGene Therapeutics and the University of Pennsylvania. \nEnsure you are part of the most anticipated gene editing event of the year! \nTo know more visit: https://ter.li/rd7cax
URL:http://www.pharmajournalist.com/event/6th-genome-editing-therapeutics-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250929
DTEND;VALUE=DATE:20251002
DTSTAMP:20260515T044410
CREATED:20250701T122415Z
LAST-MODIFIED:20250701T145003Z
UID:41426-1759104000-1759363199@www.pharmajournalist.com
SUMMARY:LEAP TA: Life Sciences
DESCRIPTION:As 2025 shapes up to be a transformative year for talent acquisition in life sciences\, the 7th LEAP TA: Life Sciences returns to Boston\, MA this September (29 – October 1)\, uniting over 120 senior TA professionals from industry pioneers including Pfizer\, AbbVie\, Bristol Myers Squibb\, Bayer\, Edwards Lifesciences\, The Jackson Laboratory\, and more. \nThis is the only event dedicated entirely to helping biopharma reimagine how they attract\, engage\, and retain top talent in an increasingly complex hiring landscape. In a time of political uncertainty\, evolving regulations\, and rapid scientific advancement\, hiring in life sciences has never been more challenging\, or vital to long-term success. \nOver three high-impact days\, uncover how TA leaders are: \n\nNavigating visa challenges\, DEI pushback\, and new workforce expectations\nLeveraging AI\, redefined employer branding\, and technology to build future-ready teams\nDriving value-driven recruitment in the face of political and market disruption\nAdapting to shifting skills requirements through innovative sourcing strategies\n\nFrom small biotechs to global pharma giants\, this event spotlights real-world case studies and actionable insights from across the industry\, all designed to equip you with the tools to compete for niche\, scientific\, and technical talent in today’s market. \nWhether you’re looking to streamline time-to-fill\, reduce turnover\, or build a more resilient and diverse talent pipeline\, LEAP TA: Life Sciences offers a unique opportunity to step back from day-to-day execution\, connect with your peers\, and rethink what’s possible in TA. \nJoin the most forward-thinking talent acquisition leaders in life sciences to shape the future of hiring in 2025 and beyond.
URL:http://www.pharmajournalist.com/event/leap-ta-life-sciences-2025/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, 02116\, United States
ORGANIZER;CN="LEAP HR":MAILTO:leaphr@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250929
DTEND;VALUE=DATE:20251002
DTSTAMP:20260515T044410
CREATED:20250717T103452Z
LAST-MODIFIED:20250717T103536Z
UID:41520-1759104000-1759363199@www.pharmajournalist.com
SUMMARY:9th MASH Drug Development Summit
DESCRIPTION:The 9th MASH Drug Development Summit is the definitive meeting for pharma and biotech leaders advancing the next generation of therapies for MASH. With the approval of Rezdiffra signaling a new era\, the race is on to deliver more effective\, patient-centered treatments. \nThis year\, dive into novel mechanisms of action\, non-invasive biomarkers\, and strategic combination and sequential therapies. Hear from experts at Eli Lilly\, Pfizer\, Takeda\, Madrigal\, Akero\, 89 Bio\, and more as they share cutting-edge research and clinical strategies targeting diverse patient populations. \nJoin 60+ MASH scientists and drug developers\, gain critical insights\, and build meaningful collaborations over 10+ hours of dedicated networking. Don’t miss the Pre-Conference Combination & Sequential Therapy Day for a focused deep dive into emerging treatment approaches. \nFind out more now: https://ter.li/d9r0pm
URL:http://www.pharmajournalist.com/event/9th-mash-drug-development-summit/
LOCATION:Hyatt Regency Boston / Cambridge\, 575 Memorial Dr\, Cambridge\, MA\, 02139\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR